Immunovant, Inc. (IMVT)

Last Closing Price: 32.67 (2026-06-04)

Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Immunovant, Inc. (IMVT) Expense Ratio data is not available.

Figures for fiscal year ending 2026-03-31
Income Statement Financials
--
$-505.61M
--
--
$532.90M
$-532.90M
$27.51M
$-505.39M
$-505.39M
$-505.61M
$-505.61M
$-505.61M
$-505.61M
$-532.90M
$-532.49M
182.42M
182.42M
$-2.77
$-2.77
Balance Sheet Financials
$948.82M
$0.44M
$8.20M
$957.01M
$104.42M
--
--
$104.42M
$852.59M
$852.59M
$852.59M
203.94M
Cash Flow Statement Financials
$-407.31M
$-0.01M
$595.76M
$713.97M
$902.11M
$188.14M
$55.72M
--
--
Fundamental Metrics & Ratios
9.09
--
--
--
--
--
--
--
--
--
--
$-407.32M
--
Expense Ratio
--
--
--
--
--
--
-59.30%
-59.30%
-52.83%
-59.30%
$4.18
$-2.23
$-2.23